
PQM130
CAS No. 2089415-51-8
PQM130( —— )
Catalog No. M26392 CAS No. 2089415-51-8
PQM130 is a Feruloyl-Donepezil Hybrid compound against the neurotoxicity induced by Aβ1-42 oligomer (AβO) and shows anti-inflammatory activity. PQM130 can be used in anti-AD studies.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 35 | Get Quote |
![]() ![]() |
10MG | 58 | Get Quote |
![]() ![]() |
25MG | 115 | Get Quote |
![]() ![]() |
50MG | 192 | Get Quote |
![]() ![]() |
100MG | 311 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePQM130
-
NoteResearch use only, not for human use.
-
Brief DescriptionPQM130 is a Feruloyl-Donepezil Hybrid compound against the neurotoxicity induced by Aβ1-42 oligomer (AβO) and shows anti-inflammatory activity. PQM130 can be used in anti-AD studies.
-
DescriptionPQM130 is a Feruloyl-Donepezil Hybrid compound against the neurotoxicity induced by Aβ1-42 oligomer (AβO) and shows anti-inflammatory activity. PQM130 can be used in anti-AD studies.(In Vitro):PQM130 had already shown anti-inflammatory activity in different in vivo models and neuroprotective activity in human neuronal cells.?(In Vivo):The intracerebroventricular (i.c.v.) injection of AβO in mice caused the increase of memory impairment, oxidative stress, neurodegeneration, and neuroinflammation.?Instead, PQM130 (0.5-1 mg/kg) treatment after the i.c.v. AβO injection reduced oxidative damage and neuroinflammation and induced cell survival and protein synthesis through the modulation of glycogen synthase kinase 3β (GSK3β) and extracellular signal-regulated kinases (ERK1/2).?Moreover, PQM130 increased brain plasticity and protected mice against the decline in spatial cognition.?PQM130 modulated different pathways compared to donepezil, and it is much more effective in counteracting AβO damage.?
-
In Vitro——
-
In VivoPQM130 (0.5-1 mg/kg, i.p., daily for 10 days) treatment after the i.c.v. AβO injection reduces oxidative damage and neuroinflammation and induces cell survival and protein synthesis through the modulation of GSK3β and extracellular signal-regulated kinases (ERK1/2) . Animal Model:Adult male C57Bl/6 mice (9 weeks old, 25-30 g body weight) .Dosage:0.5 and 1.0 mg/kg.Administration:IP injection daily for 10 days.Result:Ameliorated Aβ1-42O-induced cognitive deficits in mice.Prevented Aβ1-42O-induced neuronal death in mice.Antagonized Aβ1-42O-Induced Oxidative Stress in Mice.Regulated GSK3β and ERK1/2 protein expressions in mice.Reduced Aβ1-42O-induced astrocytic activation in mice.
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2089415-51-8
-
Formula Weight381.472
-
Molecular FormulaC23H27NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 1.82 mg/mL (4.77 mM)
-
SMILESCOc1cc(\C=C\C(=O)OCC2CCN(Cc3ccccc3)CC2)ccc1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Süntar I, Küpeli Akkol E, Keles H, Yesilada E, Sarker SD, Arroo R, Baykal T. Efficacy of Daphne oleoides subsp. kurdica used for wound healing: identification of active compounds through bioassay guided isolation technique. J Ethnopharmacol. 2012 Jun 14;141(3):1058-70.
molnova catalog



related products
-
Scyllo-Inositol
Scyllo-Inositol is one of the inositol stereoisomers rare in the nature and expected as a promising disease-modifying therapeutic agent for Alzheimer's disease.
-
Amyloid β Peptide (4...
Amyloid β-Peptide (1-42) human is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease.
-
β-Amyloid 13-27
β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein. This synthetic peptide consists of amino acids 26 to 40 of beta amyloid protein. It can be used to study the kinetics of beta amyloid formation.